Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial to Reduce Pneumonia in Nursing Home Residents (PRIDE)

This study has been completed.
Information provided by (Responsible Party):
Yale University Identifier:
First received: September 10, 2009
Last updated: November 7, 2014
Last verified: November 2014
Results First Received: December 6, 2013  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Single Blind (Outcomes Assessor);   Primary Purpose: Prevention
Conditions: Pneumonia
Lower Respiratory Tract Infection
Interventions: Other: Enhanced Oral Care
Other: Usual oral care

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Usual Care

The usual oral care provided at the nursing home

Usual oral care : Usual oral care and feeding positioning

Enhanced Oral Care Enhanced Oral Care : oral brushing plus oral chlorhexidine plus upright feeding positioning

Participant Flow for 2 periods

Period 1:   Allocation
    Usual Care     Enhanced Oral Care  
STARTED     400     434  
COMPLETED     400     434  
NOT COMPLETED     0     0  

Period 2:   Follow Up
    Usual Care     Enhanced Oral Care  
STARTED     400     434  
COMPLETED     298     277  
NOT COMPLETED     102     157  
Death                 88                 122  
Facility Withdrawal                 7                 23  
Discharged from Facility                 7                 12  

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Enhanced Oral Care Study participants receiving 'Enhanced Oral Care' in the study
Usual Oral Care Study participants receiving 'Usual Oral Care' in the study.
Total Total of all reporting groups

Baseline Measures
    Enhanced Oral Care     Usual Oral Care     Total  
Number of Participants  
[units: participants]
  434     400     834  
[units: years]
Mean ± Standard Deviation
  86.5  ± 8.0     86.1  ± 8.3     86.3  ± 8.1  
[units: participants]
Female     329     307     636  
Male     105     93     198  

  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Pneumonia   [ Time Frame: 2.5 years ]

2.  Secondary:   Lower Respiratory Tract Infection Other Than Pneumonia   [ Time Frame: 2.5 years ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data

Participant flow and outcome information pertains to data collected through 10/25/2012- the official trial termination date.

Serious and Other Adverse Event information pertains to requested surveillance of subjects through 12/10/2012 per the NIA.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio
Organization: Yale University School of Medicine
phone: (203) 785-7571

No publications provided

Responsible Party: Yale University Identifier: NCT00975780     History of Changes
Other Study ID Numbers: 0609001783, R01AG030575
Study First Received: September 10, 2009
Results First Received: December 6, 2013
Last Updated: November 7, 2014
Health Authority: United States: Institutional Review Board